SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbla... von Ben-Josef, Edgar, Guthrie, Katherine A, El-Khoueiry, Anthony B, Corless, Christopher L, Zalupski, Mark M, Lowy, Andrew M, Thomas, Jr, Charles R, Alberts, Steven R, Dawson, Laura A, Micetich, Kenneth C, Thomas, Melanie B, Siegel, Abby B, Blanke, Charles D

Volltext

Identification of targetable FGFR gene fusions in diverse cancers von Wu, Yi-Mi, Su, Fengyun, Kalyana-Sundaram, Shanker, Khazanov, Nickolay, Ateeq, Bushra, Cao, Xuhong, Lonigro, Robert J, Vats, Pankaj, Wang, Rui, Lin, Su-Fang, Cheng, Ann-Joy, Kunju, Lakshmi P, Siddiqui, Javed, Tomlins, Scott A, Wyngaard, Peter, Sadis, Seth, Roychowdhury, Sameek, Hussain, Maha H, Feng, Felix Y, Zalupski, Mark M, Talpaz, Moshe, Pienta, Kenneth J, Rhodes, Daniel R, Robinson, Dan R, Chinnaiyan, Arul M

Volltext

A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation With Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients With Unresectable Pancreatic Cancer von Ben-Josef, Edgar, MD, Schipper, Mathew, PhD, Francis, Isaac R., MD, Hadley, Scott, PhD, Ten-Haken, Randall, PhD, Lawrence, Theodore, MD, PhD, Normolle, Daniel, PhD, Simeone, Diane M., MD, Sonnenday, Christopher, MD, Abrams, Ross, MD, Leslie, William, MD, Khan, Gazala, MD, Zalupski, Mark M., MD

Volltext

A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor von Bendell, Johanna C, Javle, Milind, Bekaii-Saab, Tanios S, Finn, Richard S, Wainberg, Zev A, Laheru, Daniel A, Weekes, Colin D, Tan, Benjamin R, Khan, Gazala N, Zalupski, Mark M, Infante, Jeffrey R, Jones, Suzanne, Papadopoulos, Kyriakos P, Tolcher, Anthony W, Chavira, Renae E, Christy-Bittel, Janna L, Barrett, Emma, Patnaik, Amita

Volltext

Phase I Trial of Radiation Dose Escalation With Concurrent Weekly Full-Dose Gemcitabine in Patients With Advanced Pancreatic Cancer von MCGINN, Cornelius J, ZALUPSKI, Mark M, LAWRENCE, Theodore S, SHUREIQI, Imad, ROBERTSON, John M, ECKHAUSER, Frederic E, SMITH, David C, BROWN, Diane, HEJNA, Gwen, STRAWDERMAN, Myla, NORMOLLE, Daniel

Volltext

Full-Dose Gemcitabine and Concurrent Radiotherapy for Unresectable Pancreatic Cancer von Murphy, James D., B.S, Adusumilli, Saroja, M.D, Griffith, Kent A., M.P.H., M.S, Ray, Michael E., M.D., Ph.D, Zalupski, Mark M., M.D, Lawrence, Theodore S., M.D., Ph.D, Ben-Josef, Edgar, M.D

Volltext

Genomics driven precision oncology in advanced biliary tract cancer improves survival von Kumar-Sinha, Chandan, Vats, Pankaj, Tran, Nguyen, Robinson, Dan R., Gunchick, Valerie, Wu, Yi-Mi, Cao, Xuhong, Ning, Yu, Wang, Rui, Rabban, Erica, Bell, Janice, Shankar, Sunita, Mannan, Rahul, Zhang, Yuping, Zalupski, Mark M., Chinnaiyan, Arul M., Sahai, Vaibhav

Volltext

Reply to “Is there a role for combined anti–PD‐1/CTLA‐4 checkpoint blockade in the management of advanced biliary tract cancers?” von Sahai, Vaibhav, Zalupski, Mark M.

Volltext

A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma von Enzler, T., Nguyen, A., Misleh, J., Cline, V.J., Johns, M., Shumway, N., Paulson, S., Siegel, R., Larson, T., Messersmith, W., Richards, D., Chaves, J., Pierce, E., Zalupski, M., Sahai, V., Orr, D., Ruste, S.A., Haun, A., Kawabe, T.

Volltext

Quality of Life in a Prospective, Multicenter Phase 2 Trial of Neoadjuvant Full-Dose Gemcitabine, Oxaliplatin, and Radiation in Patients With Resectable or Borderline Resectable Pa... von Serrano, Pablo E., MD, MPH, MSc, Herman, Joseph M., MD, MSc, Griffith, Kent A., MSc, Zalupski, Mark M., MD, Kim, Edward J., MD, PhD, Bekaii-Saab, Tanios S., MD, Ben-Josef, Edgar, MD, Dawson, Laura A., MD, Ringash, Jolie, MD, MSc, Wei, Alice C., MD, MSc

Volltext

Full-Dose Gemcitabine With Concurrent Radiation Therapy in Patients With Nonmetastatic Pancreatic Cancer: A Multicenter Phase II Trial von SMALL, William, BERLIN, Jordan, KINSELLA, Timothy J, MERCHANT, Nipun B, HOFFMAN, John P, BENSON, Al B, NICOL, Steven, XU, Rong M, GILL, John F, MCGINN, Cornelius J, FREEDMAN, Gary M, LAWRENCE, Theodore, TALAMONTI, Mark S, MULCAHY, Mary F, BAPSI CHAKRAVARTHY, A, KONSKI, Andre A, ZALUPSKI, Mark M, PHILIP, Philip A

Volltext

HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarci... von Hingorani, Sunil R, Zheng, Lei, Bullock, Andrea J, Seery, Tara E, Harris, William P, Sigal, Darren S, Braiteh, Fadi, Ritch, Paul S, Zalupski, Mark M, Bahary, Nathan, Oberstein, Paul E, Wang-Gillam, Andrea, Wu, Wilson, Chondros, Dimitrios, Jiang, Ping, Khelifa, Sihem, Pu, Jie, Aldrich, Carrie, Hendifar, Andrew E

Volltext

A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma von Talamonti, Mark S, Small, Jr, William, Mulcahy, Mary F, Wayne, Jeffrey D, Attaluri, Vikram, Colletti, Lisa M, Zalupski, Mark M, Hoffman, John P, Freedman, Gary M, Kinsella, Timothy J, Philip, Philip A, McGinn, Cornelius J

Volltext

Integrative clinical genomics of metastatic cancer von Robinson, Dan R., Wu, Yi-Mi, Lonigro, Robert J., Vats, Pankaj, Cobain, Erin, Everett, Jessica, Cao, Xuhong, Rabban, Erica, Kumar-Sinha, Chandan, Raymond, Victoria, Schuetze, Scott, Alva, Ajjai, Siddiqui, Javed, Chugh, Rashmi, Worden, Francis, Zalupski, Mark M., Innis, Jeffrey, Mody, Rajen J., Tomlins, Scott A., Lucas, David, Baker, Laurence H., Ramnath, Nithya, Schott, Ann F., Hayes, Daniel F., Vijai, Joseph, Offit, Kenneth, Stoffel, Elena M., Roberts, J. Scott, Smith, David C., Kunju, Lakshmi P., Talpaz, Moshe, Cieślik, Marcin, Chinnaiyan, Arul M.

Volltext

Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer von Cuneo, Kyle C, Morgan, Meredith A, Sahai, Vaibhav, Schipper, Matthew J, Parsels, Leslie A, Parsels, Joshua D, Devasia, Theresa, Al-Hawaray, Mahmoud, Cho, Clifford S, Nathan, Hari, Maybaum, Jonathan, Zalupski, Mark M, Lawrence, Theodore S

Volltext

The Quality-of-Life Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer von Herman, Joseph M., MD, MSc, Narang, Amol K., MD, Griffith, Kent A., MPH, MS, Zalupski, Mark M., MD, Reese, Jennifer B., PhD, Gearhart, Susan L., MD, Azad, Nolifer S., MD, Chan, June, MD, Olsen, Leah, NP, Efron, Jonathan E., MD, Lawrence, Theodore S., MD, PhD, Ben-Josef, Edgar, MD

Volltext

Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials von Ledenko, Matthew, Antwi, Samuel O., Arima, Shiho, Driscoll, Julia, Furuse, Junji, Klümpen, Heinz-Josef, Larsen, Finn Ole, Lau, David K., Maderer, Annett, Markussen, Alice, Moehler, Markus, Nooijen, Lynn E., Shaib, Walid L., Tebbutt, Niall C., André, Thierry, Ueno, Makoto, Woodford, Rachel, Yoo, Changhoon, Zalupski, Mark M., Patel, Tushar

Volltext

A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers von El-Rayes, B.F., Zalupski, M., Bekai-Saab, T., Heilbrun, L.K., Hammad, N., Patel, B., Urba, S., Shields, A.F., Vaishampayan, U., Dawson, S., Almhanna, K., Smith, D., Philip, P.A.

Volltext

A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT‐01 von Sahai, Vaibhav, Griffith, Kent A., Beg, Muhammad S., Shaib, Walid L., Mahalingam, Devalingam, Zhen, David B., Deming, Dustin A., Zalupski, Mark M.

Volltext

Pilot clinical trial of hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinoma von Kim, Edward J, Sahai, Vaibhav, Abel, Ethan V, Griffith, Kent A, Greenson, Joel K, Takebe, Naoko, Khan, Gazala N, Blau, John L, Craig, Ronald, Balis, Ulysses G, Zalupski, Mark M, Simeone, Diane M

Volltext